Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
FEBS Letters|October 27, 2025
Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemiaMaike BuchnerCurrent Opinion in Hematology|May 10, 2014
Targeting the B-cell receptor signaling pathway in B lymphoid malignanciesMaike Buchner, Markus MüschenImmunological Reviews|December 17, 2014
Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemiaMaike Buchner, Srividya Swaminathan, Zhengshan Chen, et al.Scientific Reports|February 3, 2025
Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease modelLisa Pfeuffer, Viola Siegert, Riccardo Trozzo, et al.Cancer Immunology, Immunotherapy : CII|September 18, 2010
Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cellsMax Warncke, Maike Buchner, Gudrun Thaller, et al.Blood|March 26, 2010
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemiaMaike Buchner, Constance Baer, Gabriele Prinz, et al.Proceedings of the National Academy of Sciences of the United States of America|March 7, 2018
Foxp1 controls mature B cell survival and the development of follicular and B-1 B cellsThomas Patzelt, Selina J Keppler, Oliver Gorka, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2018
Nanomedicines for the treatment of hematological malignanciesAnil K Deshantri, Aida Varela Moreira, Veronika Ecker, et al.The Journal of Experimental Medicine|October 19, 2020
Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemiaBegüm Alankus, Veronika Ecker, Nathalie Vahl, et al.Plos One|July 21, 2010
Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humansPeter Stachon, Anna Missiou, Carina Walter, et al.Pageof 3